BlackRock Inc. - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 43 filers reported holding VYNE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$132,874
-32.6%
885,833
-0.2%
0.00%
Q3 2022$197,000
-43.1%
887,313
-0.3%
0.00%
Q2 2022$346,000
-46.9%
889,609
-11.3%
0.00%
Q1 2022$652,000
-36.5%
1,002,594
-0.5%
0.00%
Q4 2021$1,027,000
-28.7%
1,007,353
-2.9%
0.00%
Q3 2021$1,441,000
-60.4%
1,037,271
-0.0%
0.00%
Q2 2021$3,642,000
-85.2%
1,037,677
-71.2%
0.00%
-100.0%
Q1 2021$24,689,0003,606,7730.00%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,670,000$1,038,0001.04%
DELTEC ASSET MANAGEMENT LLC 30,000$12,0000.00%
Tekla Capital Management LLC 135,395$53,0000.00%
Virtu Financial LLC 64,838$25,0000.00%
TWO SIGMA SECURITIES, LLC 127,844$50,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$24,0000.00%
Beacon Pointe Advisors, LLC 75,000$28,0000.00%
Cetera Advisor Networks LLC 115,000$45,0000.00%
TOBIAS FINANCIAL ADVISORS, INC. 11,000$4,0000.00%
Russell Investments Group, Ltd. 3,375$1,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders